Benchmark Downgrades Omnicell (OMCL) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Omnicell (OMCL) PT Lowered to $75 at BTIG
November 3, 2022 5:54 AM EDTBTIG analyst David Larsen lowered the price target on Omnicell (NASDAQ: OMCL) to $75.00 (from $160.00) while maintaining a Buy rating.... More
Omnicell (OMCL) Tops Q3 EPS by 5c; Lowers Outlook
November 2, 2022 8:30 AM EDTOmnicell (NASDAQ: OMCL) reported Q3 EPS of $1.00, $0.05 better than the analyst estimate of $0.95. Revenue for the quarter came in at $348 million versus the consensus estimate of $363.24 million.
GUIDANCE:
Omnicell sees Q4 2022 EPS of $0.05-$0.15, versus the consensus of $1.21. Omnicell sees Q4... More
